New Echota Biotechnology
Biotech · Private
Cell-penetrating peptide (CPP) adaptors that deliver CRISPR-Cas genome editing machinery into mammalian cell nuclei.
- Grants
- $900K
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2015201620172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Novel Technologies for intracellular manipulation | $226,795 | |
| Federal grant | Department of Health and Human Services · Phase I · Novel Technologies for intracellular manipulation | $226,795 | |
| Federal grant | Department of Health and Human Services · Phase I · Cell-penetrating peptides for enhanced delivery of CRISPR/Cas | $223,122 | |
| Federal grant | Department of Health and Human Services · Phase I · Cell-penetrating peptides for enhanced delivery of CRISPR/Cas | $223,122 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2466 | CURADEL SURGICAL INNOVATIONS, INC. | — | $24M |
| 2467 | Vaxart, Inc. | — | $23M |
| 2468 | PULMOTECT, INC | — | $22M |
| 2469 | New Echota Biotechnology | — | — |
| 2470 | Rocket Pharmaceuticals Ltd. | — | $28M |
| 2471 | BIOSTRATEGIES LC | — | — |
| 2472 | Fulgent Pharma LLC | — | $5.4M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.